Peptides and the Biology of Aging: Signalling Pathways, Cellular Senescence and Experimental Models

Peptides and the Biology of Aging

A single biological pathway does not control the process of aging; rather, it involves various interacting changes in cellular signalling, metabolism, mitochondrial function, the regulation of the extracellular matrix, genomic maintenance and communication specific to tissues.

Since peptides can function as signalling molecules, as receptor ligands, as modulators of intracellular pathways or as regulators of protein interactions, research into them offers various methods for investigating these processes.

The key point is that the peptides involved in ageing research do not belong to a single pharmacological class; different compounds may have entirely different molecular targets. Growth hormone-releasing peptides, copper-binding peptides and the short experimental peptide Epitalon therefore have to be assessed on the basis of their individual structures, targets and experimental evidence.

It is better to understand the research by looking at the biological pathway in question and the experimental model that was used to study it rather than considering these compounds altogether as "anti-aging peptides".

What Does Aging Biology Measure?

Aging research uses multiple molecular and cellular endpoints because no single biomarker captures the entire aging process.

Researchers could look at cellular senescence, mitochondrial activity, the responses to DNA damage, measurements related to telomeres, inflammatory signalling, the turnover of the extracellular matrix, metabolic regulation or endocrine signalling.

They also function at different levels of biology.

Just because there is a change in gene expression does not mean there is a change in protein activity. The fact that a hormone is found in altered amounts in the blood does not necessarily indicate that tissue function has changed. In the same way, an observation in cultured cells cannot simply be assumed to represent an aging phenotype at the level of the whole organism.

This makes experimental design particularly important when interpreting peptide studies.

GH and IGF-1 Signalling in Aging Research

The growth hormone and insulin-like growth factor 1 axis is one of the most extensively studied endocrine systems in aging biology.

Growth hormone secretion and circulating IGF-1 generally decline with age. This phenomenon has been investigated in relation to changes in hypothalamic signalling, pituitary function, somatostatin activity and feedback regulation. Research has also shown that the relationship between GH, IGF-1 and aging is more complicated than simply associating lower hormone concentrations with a negative aging phenotype.

Important findings have been obtained through studies in various model organisms regarding the relationship between somatotropic signalling and lifespan; in some animal models, reduced GH or IGF-1 signalling has been linked to a longer lifespan, which shows that the effects of the pathway are dependent on the context. It therefore cannot be concluded from findings in humans and animals that increasing or decreasing GH signalling has the same effect on aging.

The GH/IGF-1 axis is consequently useful as a research model for investigating endocrine regulation, receptor signalling and age-associated changes in hormone dynamics.

GHRH and Growth Hormone Secretagogue Research

Certain peptide research is concerned with the upstream regulation of the secretion of GH rather than looking directly at aging.

Compounds related to GHRH interact with the growth hormone-releasing hormone receptor, a member of the class B G protein-coupled receptor family which is associated with intracellular cAMP signalling. The substances that stimulate the release of growth hormone work via a different receptor system, mainly through the growth hormone secretagogue receptor.

This distinction matters because compounds affecting the same endocrine axis can enter the pathway at different molecular points.

It is therefore possible to carry out experimental studies on receptor activation, the characteristics of intracellular signalling, hormone pulse characteristics, feedback regulation and the differences between various experimental models.

The fact that research using GHRH analogues or growth hormone secretagogues should not simply be regarded as demonstrating an anti-aging effect must be borne in mind, since the appropriate scientific issue may be one relating to receptor pharmacology or the regulation of the somatotropic axis.

Cellular Senescence as an Aging Research Model

Cellular senescence is another major area of aging research.

Senescent cells generally exhibit stable changes in proliferation, metabolism, gene expression and secretory activity. They can develop a senescence-associated secretory phenotype involving multiple signalling molecules and extracellular factors.

To identify senescent cells researchers make use of a number of experimental methods, these being measurements of senescence-associated β-galactosidase activity, cell-cycle arrest markers, DNA damage-associated signals and changes in gene expression.

The peptides that are being studied in the context of aging might affect some of these pathways only indirectly, but it is necessary to clearly define the experimental endpoint.

A peptide which alters a senescence-associated marker in cultured cells has no systemic effect on biological ageing. The outcome can be influenced by the cell type, the passage number, the culture conditions, the length of exposure and the initial state of the cells.

Peptides and Extracellular Matrix Biology

Aging includes changes in the environment that is outside of the cells.

The collagen, proteoglycans, glycosaminoglycans and other structural elements present in the extracellular matrix have an effect on cell behaviour and the organisation of tissue.

GHK-Cu is an example of a peptide complex which has been studied in this field. GHK is a tripeptide having the ability to bind copper, and GHK-Cu has been looked at in cultured fibroblasts with regard to its effects on collagen synthesis and the extracellular matrix components.

Research has found changes in the production of collagen, in the synthesis of glycosaminoglycans and in the expression of matrix metalloproteinases in experimental fibroblast systems.

These observations are useful for studying peptide-metal interactions and extracellular matrix regulation. They should not be presented as proof of a general anti-aging effect.

It is especially important to note that since the biology of the extracellular matrix makes up only one part of the overall aging process.

Mitochondrial Signalling and Peptide Research

Mitochondria are a major focus of aging research since they control the production of ATP, redox balance, metabolite signalling and a number of pathways linked to cellular stress.

Experimental peptides have been studied with regard to mitochondrial membrane function, oxidative stress, electron transport and mitochondrial signalling.

This area requires careful interpretation because mitochondrial measurements can describe very different biological processes.

For example, alterations in membrane potential, oxygen consumption, ATP production and reactive oxygen species are not equivalent and can therefore be considered as separate endpoints; a research study must therefore specify exactly which mitochondrial parameter is under measurement.

Short peptides that are connected with mitochondrial research should also be differentiated from endogenous mitochondrial proteins or metabolic cofactors since chemical identity is important when comparing experimental materials.

Epitalon and Short Peptide Aging Research

Epitalon, also referred to as Epithalon, is a tetrapeptide made up of alanine, glutamic acid, aspartic acid and glycine.

It has been the subject of experimental research concerned with aging for many decades, and published studies have looked at cellular, animal and molecular endpoints such as gene expression, melatonin-related biology and telomerase-associated mechanisms.

A recent review mentioned the large amount of experimental work on Epitalon and at the same time pointed out that the physicochemical and structural characterisation of it is still less advanced than its biological literature.

More recent cell-based research has investigated possible relationships between Epitalon exposure, telomerase activity, telomere length and alternative lengthening of telomeres. These findings remain experimental and should be interpreted within the specific cell systems used.

Just because there is published research does not mean that a peptide extends human lifespan or reverses biological aging.

Telomeres and Peptide Research

Telomeres are repetitive DNA-protein structures located at chromosome ends. They help protect chromosome termini during cellular replication.

Telomere length is frequently investigated as an aging-associated measurement, but it is not a complete measure of biological aging.

The enzyme known as telomerase, which is involved in maintaining telomeric DNA in a number of cell types, is also examined in connection with cellular proliferation and genome stability.

Peptides and telomere biology research must therefore differentiate between a number of separate observations; a change in telomerase expression, a change in telomerase enzymatic activity and a measured change in telomere length are different experimental endpoints.

This distinction is especially important when interpreting short-term cell culture studies.

Peptides, Sirtuins and NAD-Dependent Biology

The study of NAD+ is often carried out in connection with research into peptide-based aging, but NAD+ is not in fact a peptide; it is a metabolic cofactor that takes part in redox reactions and in several signalling pathways.

Enzymes that depend on NAD+ include the sirtuins, which are involved in the regulation of protein deacetylation and other cellular processes; furthermore, the PARP enzymes use up NAD+ as part of the DNA damage response, and CD38 is also a significant source of NAD+ consumption.

It establishes a significant link between peptide research and general aging biology without implying that all the mechanisms associated with aging are mediated by peptides.

A peptide such as NAD+ should therefore be regarded as belonging to the biochemical context rather than being classified as an anti-aging peptide.

How Experimental Models Change the Interpretation

Peptide ageing research may make use of cultured cells, organoids, rodents, non-human primates or studies based on human observations and clinical data.

Each model answers a different question.

Cell culture enables experimental control and allows researchers to isolate particular molecular pathways; animal models contribute tissue-level and whole-organism interactions and human studies add further biological variability while providing a different kind of evidence.

A result observed in one model should not automatically be presented as confirmation of the same mechanism in another.

This applies especially to the subject of aging since biological aging takes place in a number of organs and systems; for instance, a molecular change in fibroblasts doesn't necessarily indicate a corresponding change in the biology of aging throughout the entire organism.

Measuring Peptide Effects in Aging Studies

For reliable research into peptides, it is necessary to have confirmed identity of the compound.

Before carrying out any biological comparisons, the sequence, molecular weight, purity, any modifications and the analytical documentation should be determined.

The selected endpoint should then correspond to the mechanism being investigated. Receptor activation may be appropriate for a receptor-targeting peptide, while extracellular matrix proteins may be more appropriate for a peptide investigated in fibroblast biology.

Time is another important variable. Signalling responses can occur within minutes or hours, whereas changes in gene expression, protein abundance, cellular phenotype or tissue architecture may require substantially different experimental windows.

Controls are just as important; for example, vehicle controls, inactive analogues, pathway inhibitors or receptor-specific controls can be used to find out if the observed response is linked to the proposed mechanism.

Why “Anti-Aging Peptides” Is Not a Single Scientific Category

The term "anti-aging peptides" brings together substances which have quite different chemical structures and biological targets.

For example, a peptide related to GHRH is part of the research on endocrine receptor signalling. GHK-Cu is a peptide complex which binds copper and is connected with research into the extracellular matrix. Epitalon is a short tetrapeptide that has been studied in a number of cellular and molecular models. Other peptides can also be studied in mitochondrial, inflammatory, neuroendocrine or protein-interaction systems.

These compounds should not be treated as interchangeable research materials.

A classification that has a scientific value therefore begins with molecular identity and mechanism rather than with a label based on an outcome.

Limitations of Current Peptide Aging Research

The evidence base remains heterogeneous.

Certain peptide pathways have decades of experimental research to support them, whereas others are based mostly on cell culture or animal models. Moreover, experimental studies can vary greatly in terms of the peptide involved, its purity, the model organism used, the exposure conditions, and the endpoints that are measured.

The GH/IGF-1 pathway shows the need for caution when making biological interpretations. Even though GH and IGF-1 levels decrease with age, studies in model organisms have shown that reduced somatotropic signalling can also be linked to a longer lifespan. This proves that a decline in a pathway associated with aging does not necessarily mean that enhancing the pathway will lead to a beneficial effect on aging.

The same applies to findings concerning telomerase, mitochondrial activity or markers of the extracellular matrix since they should stay related to the experimental system in which they were observed.

Research Use Only

This article's information is for use in scientific and laboratory research only and is not meant to be used for the diagnosis, treatment, prevention, or management of any disease or condition.

When interpreting research findings it is necessary to take into account the compound identity, the experimental model, the measured endpoint and the study conditions as reported in the original publication.

Peptide research materials should be evaluated according to documented chemical identity and analytical specifications rather than consumer-oriented aging or longevity claims.

FAQs

References

1. Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013 Jun;9(6):366-376. doi: 10.1038/nrendo.2013.67. Epub 2013 Apr 16. PubMed ↗
2. Barzilai N, Huffman DM, Muzumdar RH, Bartke A. The critical role of metabolic pathways in aging. Diabetes. 2012 Jun;61(6):1315-22. doi: 10.2337/db11-1300. PubMed ↗
3. Sonntag WE, Ramsey M, Carter CS. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev. 2005 May;4(2):195-212. doi: 10.1016/j.arr.2005.02.001. PubMed ↗
4. Bartke A, Chandrashekar V, Dominici F, Turyn D, Kinney B, Steger R, Kopchick JJ. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontology. 2003;4(1):1-8. doi: 10.1023/a:1022448532248. PubMed ↗
5. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988 Oct 10;238(2):343-6. doi: 10.1016/0014-5793(88)80509-x. PubMed ↗
6. Wegrowski Y, Maquart FX, Borel JP. Stimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Life Sci. 1992;51(13):1049-56. doi: 10.1016/0024-3205(92)90504-i. PubMed ↗
7. Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000 Sep 22;67(18):2257-65. doi: 10.1016/s0024-3205(00)00803-1. PubMed ↗
8. Araj SK, Brzezik J, Mądra-Gackowska K, Szeleszczuk Ł. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025 Mar 17;26(6):2691. doi: 10.3390/ijms26062691. PubMed ↗
9. Al-Dulaimi S, Thomas R, Matta S, Roberts T. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025 Sep 4;26(5):178. doi: 10.1007/s10522-025-10315-x. Erratum in: Biogerontology. 2025 Nov 15;27(1):1. doi: 10.1007/s10522-025-10326-8. PubMed ↗